Windlas Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 179.29 | 175.73 | 165.38 |
| Operating Expense | 154.27 | 149.35 | 141.88 |
| Net Profit | 13.48 | 16.95 | 15.10 |
| Net Profit Margin | 7.52 | 9.65 | 9.13 |
| Earning Per Share | 6.47 | 8.15 | 7.26 |
| EBIDTA | 24.79 | 25.29 | 23.27 |
| Effective Tax Rate | 18.43 | 17.13 | 19.02 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 179.29 |
| Operating Expense | 154.27 |
| Net Profit | 13.48 |
| Net Profit Margin | 7.52 |
| Earning Per Share | 6.47 |
| EBIDTA | 24.79 |
| Effective Tax Rate | 18.43 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 630.96 | 513.08 | 465.93 |
| Operating Expenses Annual | 552.85 | 452.84 | 413.04 |
| Operating Profit Annual | 91.57 | 70.21 | 59.60 |
| Interest Annual | 1.10 | 0.79 | 1.42 |
| Depreciation | 13.20 | 12.17 | 11.93 |
| Net Profit Annual | 58.14 | 42.64 | 38.56 |
| Tax Annual | 18.88 | 14.41 | 7.48 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 630.96 |
| Operating Expenses Annual | 552.85 |
| Operating Profit Annual | 91.57 |
| Interest Annual | 1.10 |
| Depreciation | 13.20 |
| Net Profit Annual | 58.14 |
| Tax Annual | 18.88 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 3.69 | 0.55 | 15.78 |
| Cash Flow from Operations | 108.91 | 60.98 | 9 |
| Cash Flow from Investing | -92.07 | -14.11 | -154.31 |
| Cash Flow from Financing | -15.29 | -43.74 | 130.09 |
| Cash Flow at the End | 5.24 | 3.69 | 0.55 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 3.69 |
| Cash Flow from Operations | 108.91 |
| Cash Flow from Investing | -92.07 |
| Cash Flow from Financing | -15.29 |
| Cash Flow at the End | 5.24 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 14.51 | 13.68 | 12.79 |
| PBIT Margin (%) | 12.38 | 11.28 | 10.18 |
| PBT Margin (%) | 1.12 | -2.99 | 3.01 |
| Net PROFIT Margin (%) | 9.21 | 8.31 | 8.28 |
| Return On Networth / Equity (%) | 13.63 | 10.69 | 12.98 |
| Return On Networth /Employed (%) | 18.03 | 14.22 | 14.91 |
| Return On Assets (%) | 13.45 | 10.47 | 12.08 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.07 |
| Asset Turnover Ratio (%) | 1.46 | 1.26 | 1.46 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 14.51 |
| PBIT Margin (%) | 12.38 |
| PBT Margin (%) | 1.12 |
| Net PROFIT Margin (%) | 9.21 |
| Return On Networth / Equity (%) | 13.63 |
| Return On Networth /Employed (%) | 18.03 |
| Return On Assets (%) | 13.45 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 1.46 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 179.05 | 110.38 | 91.62 |
| Total Current Assets Annual | 431.24 | 353.54 | 381.63 |
| Non Current Assets Annual | 194.92 | 175.47 | 109.39 |
| Total Shareholders Funds Annual | 450.29 | 402.67 | 395.13 |
| Total Assets Annual | 626.16 | 529.01 | 491.03 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 179.05 |
| Total Current Assets Annual | 431.24 |
| Non Current Assets Annual | 194.92 |
| Total Shareholders Funds Annual | 450.29 |
| Total Assets Annual | 626.16 |
EPS (INR)
Expected
6.45
Reported
6.47
Surprise
0.31%
Mar 2024
EPS beaten by 0.31%
Dec 2023
EPS beaten by 0.00%
Sep 2023
EPS beaten by 0.00%
